Get startedLog in
    Picture of PharmAbcine logo

    208340 — PharmAbcine News Story

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: PharmAbcine Signs Research Collaboration Deal With Wuxi Shuangliang Biotechnology To Evaluate Combination Therapy To Treat NSCLC

    Picture of PharmAbcine logoPharmAbcine
    03/08/2020 14:52
    Aug 3 (Reuters) - PharmAbcine Inc  208340.KQ :
    * PHARMABCINE SIGNS A RESEARCH COLLABORATION AGREEMENT WITH
WUXI
SHUANGLIANG BIOTECHNOLOGY (SLBIO) TO EVALUATE A COMBINATION
THERAPY TO TREAT NSCLC

Source text for Eikon:  ID:nPn8zVRFTa 
Further company coverage:  208340.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on PharmAbcine

    See all news